45 results
424B3
CYTH
Cyclo Therapeutics Inc - Ordinary Shares
21 Nov 23
Prospectus supplement
9:15am
approval and the stockholder vote required, interested party transactions, compliance with health care matters, preclinical development and clinical trials
S-4/A
CYTH
Cyclo Therapeutics Inc - Ordinary Shares
20 Nov 23
Registration of securities issued in business combination transactions (amended)
8:50am
required, interested party transactions, compliance with health care matters, preclinical development and clinical trials, pharmaceutical development
S-4
CYTH
Cyclo Therapeutics Inc - Ordinary Shares
7 Nov 23
Registration of securities issued in business combination transactions
4:45pm
plans, environmental matters, material contracts, board approval and the stockholder vote required, interested party transactions, compliance with health … care matters, preclinical development and clinical trials, pharmaceutical development and marketing regulatory matters and the opinion of MTS
425
EX-2.1
u9hp7yr ktniun99y
21 Sep 23
Business combination disclosure
4:28pm
8-K
EX-2.1
tu41oknyx8rg
21 Sep 23
Cyclo Therapeutics, Inc. and Applied Molecular Transport Inc. Enter into a Definitive Merger Agreement
4:28pm
424B4
fsfougxw e3a
11 Dec 20
Prospectus supplement with pricing info
1:38pm